Lumida
/TNDM
⌘K
Tandem Diabetes Care Inc

Tandem Diabetes Care Inc

TNDM
$17.11USD↓-6.55%-1.20 today

MARKET CAP

1.2B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$17 – $19

52W RANGE

$11
$30

AI Summary

Stalk
TrimMedium

TNDM remains in a clear medium-term downtrend following a decisive support failure and series of lower lows. While RSI is oversold and price is extended below key EMAs and SMAs, sellers maintain control and further downside toward the next structural floor is likely. Execution of bearish positions should be deferred until a corrective bounce back into the $19.40–$19.80 former support zone, where resistance can be reestablished.

  • ↑Q1 2026 revenue rose 7% YoY to $247 M alongside 29K pump shipments.
  • ↑Mobi tubeless system and Control IQ for Type 2 to double addressable market.
  • ↓Profitability weak with negative earnings yield and poor returns.
Full analysis →

Buying

8

institutions

Selling

4

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY11.58 M174.79 M+892.28 K-14.7%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL1.85 M27.98 M+-422.99 K-35.9%0.00%
MM

Millennium Management LLC

Q2 2026

BUY1.31 M19.79 M+550.07 K+35.6%0.01%
WP

Woodline Partners LP

Q2 2026

BUYNEW1.31 M19.73 M+1.31 M+0.0%0.06%
PA

Point72 Asset Management, L.P.

Q2 2026

BUY910.90 K13.75 M+400.43 K+40.5%0.02%
AC

Aqr Capital Management LLC

Q2 2026

BUY533.84 K8.06 M+201.92 K+26.6%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL349.65 K5.53 M+-140.00-19.2%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY59.62 K1.14 M+29.81 K+74.3%0.00%
MG

Man Group Plc

Q2 2026

BUYNEW50.98 K769.24 K+50.98 K+0.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY41.02 K619.01 K+2.69 K-15.8%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL260.003.92 K+-173.00-52.7%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL0.000.00+-58.23 K-100.0%0.00%